or browse our products catalogue
Anti-human CD4 FITC conjugated 0.5ml
Biological activities of Rituximab WHO 1st International Standard
WHO International Standard 1st International Standard for Infliximab
Adalimumab (1st WHO International Standard)
Bevacizumab (1st WHO International Standard)
Trastuzumab (1st WHO international Standard)
1st International Standard 2025 Anti-drug antibodies to adalimumab (neutralisation assays)
1st International Standard 2025 Anti-drug antibodies to adalimumab (binding assys)
1st International Standard 2022 for the in vitro bioactivities of Cetuximab
Golimumab
1st International Standard for Ranibizumab
WHO International Reference Reagent Anti-drug antibodies to adalimumab (detection of low activity)
WHO International Reference Reagent Anti-drug antibodies to adalimumab (detection of low affinity)